XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation
3 Months Ended
May 01, 2021
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Note 13 – Share-Based Compensation
We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (“RSAs”). The 2018 Plan
a
uthorizes the issuance of up to
 950,000 shares of common stock, plus an additional number of shares equal to the number of shares subject to awards granted under previous equity incentive plans that are forfeited, cancelled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018
Plan, there were 
145,534
 
unvested RSUs; 75,926 unvested PSUs; 48,000 unvested RSAs and options to purchase an aggregate of
 135,500
 
shares outstanding as of May 1, 2021. 
In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 or 2015 plans, but outstanding awards will continue to be governed by those plans. As of May 1, 2021, options to purchase an aggregate of 327,418 shares were outstanding under the 2007 Plan and 3,750
unvested RSUs and options to purchase an aggregate of 
141,375
shares
were outstanding under the 2015 Plan.
We also have a
Non-Employee
Director Annual Compensation Program (the “Program”), under which each of our
non-employee
directors automatically receives a grant of restricted stock on the date of their
re-election
to our board of directors. The number of whole shares granted is equal to the number calculated by dividing the stock component of the director compensation amount determined by the compensation committee for that year by the fair market value of our stock on that day. The value of the restricted stock award for fiscal 2022 is $60,000. Shares of restricted stock granted under the Program become vested on the first anniversary of the date of grant, conditioned upon the recipient’s continued service on our board of directors through that date.
Share-based compensation expense was recognized as follows: 
 
 
  
Three Months Ended
 
(In thousands)
  
May 1,
2021
 
  
May 2,
2020
 
Stock Options
   $  105      $  133  
Restricted Stock Awards and Restricted Stock Units
     370        357  
Employee Stock Purchase Plan
     3        5  
Total
   $ 478      $ 495  
Stock Options
There were no stock options granted during the three months ended May 1, 2021 and May 2, 2020.
Aggregated information regarding stock option activity for the three months ended May 1, 2021 is summarized below:
 
 
  
Number of
Options
 
  
Weighted Average
Exercise Price
 
Outstanding at January 31, 2021
     622,083      $  14.63  
Granted
     —          —    
Exercised
     (3,775      8.84  
Forfeited
     (14,015      14.96  
Canceled
     —          —    
 
  
 
 
 
  
 
 
 
Outstanding at May 1, 2021
     604,293      $ 14.66  
    
 
 
    
 
 
 
Set forth below is a summary of options outstanding at May 1, 2021:
 
Outstanding
 
  
Exercisable
 
Range of
Exercise prices
  
Number
of
Shares
 
  
Weighted-
Average
Exercise
Price
 
  
Weighted-
Average
Remaining
Contractual Life
 
  
Number
of
Shares
 
  
Weighted-
Average
Exercise
Price
 
  
Weighted
Average
Remaining
Contractual
Life
 
$5.00-10.00
     37,244      $ 7.97        1.2        37,244      $ 7.97        1.2  
$10.01-15.00
     349,299      $  13.62        4.6        337,299      $  13.61        4.5  
$15.01-20.00
     217,750      $ 17.47        6.6        165,492      $ 17.21        6.4  
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
       604,293      $ 14.66        5.1        540,035      $ 14.32        4.9  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
As of May 1, 2021, there was approximately $0.1 million of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 0.7 years.
Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)
Aggregated information regarding RSU and RSA activity for the three months ended May 1, 2021 is summarized below: 
 
 
 
  
RSAs & RSUs
 
  
Weighted Average
Grant Date Fair Value
 
Outstanding at January 31, 2020
     197,413      $ 9.96  
Granted
     124,096        14.26  
Vested
     (48,299      10.26  
Forfeited
     —          —    
 
  
 
 
 
  
 
 
 
Outstanding at May 1, 2021
     273,210      $  11.86  
    
 
 
    
 
 
 
As of May 1, 2021, there was approximately $2.5 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 1.1 years.
Employee Stock Purchase Plan
We have an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the three months ended May 1, 2021 and May 2, 2020, there were 1,813 and 3,755 shares, r
e
spectively, purchased under this plan.
As of May 1, 2021, 
8,561
shares remain available for purchase under our Employee Stock Purchase Plan.